Touchlight and Odimma Therapeutics sign deal to develop personalized cancer therapy
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, has signed a…
December 7, 2022 - 2 minutes
Touchlight, a biotechnology company pioneering enzymatic DNA production to enable genetic medicines, has signed a…